메뉴 건너뛰기




Volumn 135, Issue 22, 2017, Pages 2091-2101

Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting

(14)  Natarajan, Pradeep a,b,c   Young, Robin d   Stitziel, Nathan O e   Padmanabhan, Sandosh f,g,h   Baber, Usman i   Mehran, Roxana i   Sartori, Samantha i   Fuster, Valentin i   Reilly, Dermot F j   Butterworth, Adam d   Rader, Daniel J k   Ford, Ian g   Sattar, Naveed f   Kathiresan, Sekar a,b,c  


Author keywords

humans; hydroxymethylglutaryl CoA reductase inhibitors; polymorphism, genetic; primary prevention; vascular calcification

Indexed keywords

ANTIHYPERTENSIVE AGENT; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

EID: 85018477382     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.024436     Document Type: Article
Times cited : (392)

References (41)
  • 2
    • 84864832599 scopus 로고    scopus 로고
    • The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials
    • Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray A, Collins R, Baigent C, Cholesterol Treatment Trialists' (CTT) Collaborators The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012 380 581 590. doi: 10.1016/S0140-6736(12)60367-5.
    • (2012) Lancet , vol.380 , pp. 581-590
    • Mihaylova, B.1    Emberson, J.2    Blackwell, L.3    Keech, A.4    Simes, J.5    Barnes, E.H.6    Voysey, M.7    Gray, A.8    Collins, R.9    Baigent, C.10
  • 6
    • 0037420492 scopus 로고    scopus 로고
    • Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial
    • Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J, ASCOT Investigators Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003 361 1149 1158. doi: 10.1016/S0140-6736(03)12948-0.
    • (2003) Lancet , vol.361 , pp. 1149-1158
    • Sever, P.S.1    Dahlöf, B.2    Poulter, N.R.3    Wedel, H.4    Beevers, G.5    Caulfield, M.6    Collins, R.7    Kjeldsen, S.E.8    Kristinsson, A.9    McInnes, G.T.10    Mehlsen, J.11    Nieminen, M.12    O'Brien, E.13    Ostergren, J.14
  • 8
    • 0028883828 scopus 로고
    • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group
    • Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ, Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group. N Engl J Med 1995 333 1301 1307. doi: 10.1056/NEJM199511163332001.
    • (1995) N Engl J Med , vol.333 , pp. 1301-1307
    • Shepherd, J.1    Cobbe, S.M.2    Ford, I.3    Isles, C.G.4    Lorimer, A.R.5    MacFarlane, P.W.6    McKillop, J.H.7    Packard, C.J.8
  • 9
    • 0026781554 scopus 로고
    • A coronary primary prevention study of Scottish men aged 45-64 years: Trial design: The West of Scotland Coronary Prevention Study Group
    • A coronary primary prevention study of Scottish men aged 45-64 years: trial design: the West of Scotland Coronary Prevention Study Group. J Clin Epidemiol 1992 45 849 860
    • (1992) J Clin Epidemiol , vol.45 , pp. 849-860
  • 11
    • 33645827507 scopus 로고    scopus 로고
    • Education, 15-year risk factor progression, and coronary artery calcium in young adulthood and early middle age: The Coronary Artery Risk Development in Young Adults study
    • Yan LL, Liu K, Daviglus ML, Colangelo LA, Kiefe CI, Sidney S, Matthews KA, Greenland P, Education, 15-year risk factor progression, and coronary artery calcium in young adulthood and early middle age: the Coronary Artery Risk Development in Young Adults study. JAMA 2006 295 1793 1800. doi: 10.1001/jama.295.15.1793.
    • (2006) JAMA , vol.295 , pp. 1793-1800
    • Yan, L.L.1    Liu, K.2    Daviglus, M.L.3    Colangelo, L.A.4    Kiefe, C.I.5    Sidney, S.6    Matthews, K.A.7    Greenland, P.8
  • 14
    • 84942987885 scopus 로고    scopus 로고
    • A comprehensive 1000 genomes-based genome-wide association meta-analysis of coronary artery disease
    • CARDIoGRAMplusC4D A comprehensive 1000 genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet 2015 47 1121 1130
    • (2015) Nat Genet , vol.47 , pp. 1121-1130
  • 17
    • 84962173287 scopus 로고    scopus 로고
    • Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history
    • Tada H, Melander O, Louie JZ, Catanese JJ, Rowland CM, Devlin JJ, Kathiresan S, Shiffman D, Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history. Eur Heart J 2016 37 561 567. doi: 10.1093/eurheartj/ehv462.
    • (2016) Eur Heart J , vol.37 , pp. 561-567
    • Tada, H.1    Melander, O.2    Louie, J.Z.3    Catanese, J.J.4    Rowland, C.M.5    Devlin, J.J.6    Kathiresan, S.7    Shiffman, D.8
  • 21
    • 84863677974 scopus 로고    scopus 로고
    • Carotid plaque burden as a measure of subclinical atherosclerosis: Comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study
    • Sillesen H, Muntendam P, Adourian A, Entrekin R, Garcia M, Falk E, Fuster V, Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study. JACC Cardiovasc Imaging 2012 5 681 689. doi: 10.1016/j.jcmg.2012.03.013.
    • (2012) JACC Cardiovasc Imaging , vol.5 , pp. 681-689
    • Sillesen, H.1    Muntendam, P.2    Adourian, A.3    Entrekin, R.4    Garcia, M.5    Falk, E.6    Fuster, V.7
  • 22
    • 78449281377 scopus 로고    scopus 로고
    • Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials
    • Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R, Cholesterol Treatment Trialists' (CTT) Collaboration Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010 376 1670 1681. doi: 10.1016/S0140-6736(10)61350-5.
    • (2010) Lancet , vol.376 , pp. 1670-1681
    • Baigent, C.1    Blackwell, L.2    Emberson, J.3    Holland, L.E.4    Reith, C.5    Bhala, N.6    Peto, R.7    Barnes, E.H.8    Keech, A.9    Simes, J.10    Collins, R.11
  • 31
    • 0037118704 scopus 로고    scopus 로고
    • Heritability of coronary artery calcium quantity measured by electron beam computed tomography in asymptomatic adults
    • Peyser PA, Bielak LF, Chu JS, Turner ST, Ellsworth DL, Boerwinkle E, Sheedy PF, Heritability of coronary artery calcium quantity measured by electron beam computed tomography in asymptomatic adults. Circulation 2002 106 304 308
    • (2002) Circulation , vol.106 , pp. 304-308
    • Peyser, P.A.1    Bielak, L.F.2    Chu, J.S.3    Turner, S.T.4    Ellsworth, D.L.5    Boerwinkle, E.6    Sheedy, P.F.7
  • 36
    • 84908179151 scopus 로고    scopus 로고
    • A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease
    • Karmali KN, Goff DC Jr, Ning H, Lloyd-Jones DM, A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease. J Am Coll Cardiol 2014 64 959 968. doi: 10.1016/j.jacc.2014.06.1186.
    • (2014) J Am Coll Cardiol , vol.64 , pp. 959-968
    • Karmali, K.N.1    Goff, Jr.D.C.2    Ning, H.3    Lloyd-Jones, D.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.